PHARMACOECONOMIC STUDY OF PRIMARY OPEN-ANGLE GLAUCOMA TREATMENT WITH CARBONIC ANHYDRASE INHIBITORS

Pharmacoeconomic study of treatment primary open-angle glaucoma with carbonic anhydrise inhibitors by mean of costefficacy and budget impact analysis. Results have shown, that Azopt has benefits compare with Dorzopt and Trusopt from cost-efficacy perspective and can be claimed dominant. Futhermore A...

Full description

Bibliographic Details

Published in:	Фармакоэкономика
Main Authors:	A. Yu. Kulikov, V. G. Serpik
Format:	Article
Language:	Russian
Published:	IRBIS LLC 2015-03-01
Subjects:	primary open-angle glaucoma pharmacoeconomic studies cost-efficacy analysis budget impact analysis dorzolamide brinzolamid
Online Access:	https://www.pharmacoeconomics.ru/jour/article/view/21